✦ LIBER ✦

The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients

✍ Scribed by Edward J. Gane; Frank Weilert; David W. Orr; Geraldine F. Keogh; Michael Gibson; Michelle M. Lockhart; Christopher M. Frampton; Kenneth M. Taylor; Robin A. J. Smith; Michael P. Murphy

Book ID: 111239297
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 261 KB
Volume: 30
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2010.02250.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: a phase II, randomized s

Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

✍ S. G. LIM; N. LEUNG; H. W. L. HANN; G. K. K. LAU; C. TREPO; H. MOMMEJA-MARIN; C. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

No beneficial effect of all-trans retino

No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: The ATRACTION study, a phase II randomised trial

✍ Schuchmann, Marcus; Kittner, Jens M.; Schlaak, Jörg F.; Klass, Dietmar M.; Eisen 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 645 KB

Interventionally implanted port catheter

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: A phase II-study and historical comparison with the surgical approach

✍ Bert Hildebrandt; Maciej Pech; Annett Nicolaou; Jan M Langrehr; Jacek Kurcz; Bir 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 319 KB

Sa1319 A Phase II, Randomized, Placebo-C

Sa1319 A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis (S-USIIT-01)

✍ Hassanein, Tarek; Box, Terry D.; Tong, Myron J.; Pozza, Renee; Rossaro, Lorenzo; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 94 KB

A phase II study of the combination of h

A phase II study of the combination of histamine dihydrochloride and interferon alpha-2b (IFN-α-2b) as initial therapy in chronic hepatitis C (HCV) patients: 48-week results

✍ Lurie, Yoav; Hyle, Sandy; Gehlsen, Kurt R. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 357 KB

Ocrelizumab, a humanized anti-CD20 monoc

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study

✍ Mark C. Genovese; Jeffrey L. Kaine; Mitchell B. Lowenstein; José Del Giudice; An 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB